544 related articles for article (PubMed ID: 29884740)
41. The proinflammatory cytokine GM-CSF downregulates fetal hemoglobin expression by attenuating the cAMP-dependent pathway in sickle cell disease.
Ikuta T; Adekile AD; Gutsaeva DR; Parkerson JB; Yerigenahally SD; Clair B; Kutlar A; Odo N; Head CA
Blood Cells Mol Dis; 2011 Dec; 47(4):235-42. PubMed ID: 21945571
[TBL] [Abstract][Full Text] [Related]
42. SOX6 Downregulation Induces
Li J; Lai Y; Luo J; Luo L; Liu R; Liu Z; Zhao W
Biomed Res Int; 2017; 2017():9496058. PubMed ID: 29333458
[TBL] [Abstract][Full Text] [Related]
43. Thiourea derivatives induce fetal hemoglobin production in-vitro: A new class of potential therapeutic agents for β-thalassemia.
Ali H; Iftikhar F; Shafi S; Siddiqui H; Khan IA; Choudhary MI; Musharraf SG
Eur J Pharmacol; 2019 Jul; 855():285-293. PubMed ID: 31100414
[TBL] [Abstract][Full Text] [Related]
44. The hydroxyurea-induced small GTP-binding protein SAR modulates gamma-globin gene expression in human erythroid cells.
Tang DC; Zhu J; Liu W; Chin K; Sun J; Chen L; Hanover JA; Rodgers GP
Blood; 2005 Nov; 106(9):3256-63. PubMed ID: 15985540
[TBL] [Abstract][Full Text] [Related]
45. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
[TBL] [Abstract][Full Text] [Related]
46. PDCD2 knockdown inhibits erythroid but not megakaryocytic lineage differentiation of human hematopoietic stem/progenitor cells.
Kokorina NA; Granier CJ; Zakharkin SO; Davis S; Rabson AB; Sabaawy HE
Exp Hematol; 2012 Dec; 40(12):1028-1042.e3. PubMed ID: 22922207
[TBL] [Abstract][Full Text] [Related]
47. Hydroxyurea-inducible SAR1 gene acts through the Giα/JNK/Jun pathway to regulate γ-globin expression.
Zhu J; Chin K; Aerbajinai W; Kumkhaek C; Li H; Rodgers GP
Blood; 2014 Aug; 124(7):1146-56. PubMed ID: 24914133
[TBL] [Abstract][Full Text] [Related]
48. A systematic review of known mechanisms of hydroxyurea-induced fetal hemoglobin for treatment of sickle cell disease.
Pule GD; Mowla S; Novitzky N; Wiysonge CS; Wonkam A
Expert Rev Hematol; 2015 Oct; 8(5):669-79. PubMed ID: 26327494
[TBL] [Abstract][Full Text] [Related]
49. Compounds of the anthracycline family of antibiotics elevate human gamma-globin expression both in erythroid cultures and in a transgenic mouse model.
Spyrou P; Phylactides M; Lederer CW; Kithreotis L; Kirri A; Christou S; Kkolou E; Kanavakis E; Anagnou NP; Stamatoyannopoulos G; Kleanthous M
Blood Cells Mol Dis; 2010; 44(2):100-6. PubMed ID: 19914848
[TBL] [Abstract][Full Text] [Related]
50. Inhibition of G9a methyltransferase stimulates fetal hemoglobin production by facilitating LCR/γ-globin looping.
Krivega I; Byrnes C; de Vasconcellos JF; Lee YT; Kaushal M; Dean A; Miller JL
Blood; 2015 Jul; 126(5):665-72. PubMed ID: 25979948
[TBL] [Abstract][Full Text] [Related]
51. Reactivation of Fetal Hemoglobin for Treating β-Thalassemia and Sickle Cell Disease.
Cui S; Engel JD
Adv Exp Med Biol; 2017; 1013():177-202. PubMed ID: 29127681
[TBL] [Abstract][Full Text] [Related]
52. Fetal haemoglobin induction in sickle cell disease.
Paikari A; Sheehan VA
Br J Haematol; 2018 Jan; 180(2):189-200. PubMed ID: 29143315
[TBL] [Abstract][Full Text] [Related]
53. HMGA2 Moderately Increases Fetal Hemoglobin Expression in Human Adult Erythroblasts.
de Vasconcellos JF; Lee YT; Byrnes C; Tumburu L; Rabel A; Miller JL
PLoS One; 2016; 11(11):e0166928. PubMed ID: 27861570
[TBL] [Abstract][Full Text] [Related]
54. Role of cyclic nucleotides in fetal hemoglobin induction in cultured CD34+ cells.
Keefer JR; Schneidereith TA; Mays A; Purvis SH; Dover GJ; Smith KD
Exp Hematol; 2006 Sep; 34(9):1151-61. PubMed ID: 16939808
[TBL] [Abstract][Full Text] [Related]
55. Hydroxymethylcytosine and demethylation of the γ-globin gene promoter during erythroid differentiation.
Ruiz MA; Rivers A; Ibanez V; Vaitkus K; Mahmud N; DeSimone J; Lavelle D
Epigenetics; 2015; 10(5):397-407. PubMed ID: 25932923
[TBL] [Abstract][Full Text] [Related]
56. Monoterpenes as therapeutic candidates to induce fetal hemoglobin synthesis and up-regulation of gamma-globin gene: An in vitro and in vivo investigation.
Iftikhar F; Khan MBN; Musharraf SG
Eur J Pharmacol; 2021 Jan; 891():173700. PubMed ID: 33137331
[TBL] [Abstract][Full Text] [Related]
57. Neither DNA hypomethylation nor changes in the kinetics of erythroid differentiation explain 5-azacytidine's ability to induce human fetal hemoglobin.
Mabaera R; Greene MR; Richardson CA; Conine SJ; Kozul CD; Lowrey CH
Blood; 2008 Jan; 111(1):411-20. PubMed ID: 17916742
[TBL] [Abstract][Full Text] [Related]
58. Mechanism for fetal hemoglobin induction by hydroxyurea in sickle cell erythroid progenitors.
Baliga BS; Pace BS; Chen HH; Shah AK; Yang YM
Am J Hematol; 2000 Nov; 65(3):227-33. PubMed ID: 11074540
[TBL] [Abstract][Full Text] [Related]
59. Chemical Inhibition of Histone Deacetylases 1 and 2 Induces Fetal Hemoglobin through Activation of GATA2.
Shearstone JR; Golonzhka O; Chonkar A; Tamang D; van Duzer JH; Jones SS; Jarpe MB
PLoS One; 2016; 11(4):e0153767. PubMed ID: 27073918
[TBL] [Abstract][Full Text] [Related]
60. Hydroxyurea down-regulates BCL11A, KLF-1 and MYB through miRNA-mediated actions to induce γ-globin expression: implications for new therapeutic approaches of sickle cell disease.
Pule GD; Mowla S; Novitzky N; Wonkam A
Clin Transl Med; 2016 Mar; 5(1):15. PubMed ID: 27056246
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
